Suspension of BioMarin Clinical Trial of VOXZOGO® (vosoritide) in Noonan Syndrome
BioMarin has made the decision to discontinue development of VOXZOGO® (vosoritide) for children with Noonan…
Beth StronachSeptember 16, 2026








